Archives

AMRA Medical Launches AMRA® BCP Scan in Netherlands

AMRA Medical

AMRA Medical, the global leader in MRI-based fat distribution and muscle composition analytics, alongside Dutch preventative healthcare leader Prescan, are pleased to announce the official launch of our cutting-edge AMRA® BCP Scan service, powered by AMRA® Profiler (CE, NB 2862), in the Netherlands. The launch, which marks BCP Scan’s third new market entry of 2025 (Sweden & Germany), expands the availability of our service within the EU into the Netherlands through an exclusive partnership with Prescan, an independent health & wellness clinic in Baarn which specializes in preventive health screenings and care.

AMRA’s CEO, Olof Dahlqvist Leinhard, stated, “This is another important step in bringing our mission of driving scientific breakthroughs into the clinic by enabling deeper understanding of health and disease through MRI-based biomarkers to the global stage. By partnering with Prescan, we’re excited to help them empower individuals in the Netherlands to take proactive control of their health using AMRA® BCP Scan.”

The AMRA® BCP Scan service provides clinicians with fat distribution measurements, including visceral fat, subcutaneous fat and liver fat, in addition to muscle composition biomarkers that comprise a detailed body composition profile (BCP) to assist in the assessment of health risks. Implemented directly in the clinic, the service delivers rapid, precise, and standardized body composition measurements, contextualizing insights at the individual patient level with high accuracy.

Also Read: Lyric Names Halsey Wise as Chief Executive Officer 

At launch, Prescan will make AMRA® BCP Scan available to customers as a standalone product, and will be the only center offering BCP Scan in the Netherlands. Haif Rood Nawzad, CEO of Prescan, remarked that “This collaboration with AMRA represents an important step forward in preventive diagnostics at Prescan. By adding precise measurement of visceral fat and assisting our clinicians with assessing their metabolic risk to our offering, we further expand our advanced MRI portfolio and provide clients with clinically relevant insights that go beyond traditional imaging. It perfectly aligns with our vision to continuously innovate and improve early detection in preventive healthcare.”

Currently, AMRA® BCP Scan service is additionally available through AMRA’s service provision in the US, Canada, Sweden, Germany, the Netherlands, and the UK – with plans to roll out in more countries in 2026 and beyond.

Source: Businesswire